AB Science announces successful Phase III clinical trial with masitinib in first-line advanced pancreatic cancer

pancreatictumor
Scientific literature and results from early phase clinical trials suggest there may be a survival benefit in late-stage advanced/metastatic patients who are treated with masitinib. Credit: Shutterstock.